Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrew J. Wicks
Observed name:
Andrew Wicks
Institutions:
Institute of Cancer Research,
Breast Cancer Now,
Cancer Research UK
Observed institutions:
Institute of Cancer Research,
Breast Cancer Now,
Cancer Research UK
ORCID:
0000-0002-9307-3262
Observed ORCID:
0000-0002-9307-3262
OpenAlex ID:
A5027809093
Structural basis for allosteric PARP-1 retention on DNA breaks
2020
·
Levani Zandarashvili
, Marie-France Langelier
, et al.
·
Science
·
353
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
2022
·
Dragomir B. Krastev
, Shudong Li
, et al.
·
Nature Cell Biology
·
182
PDF
PARP Inhibitors – Trapped in a Toxic Love Affair
2021
·
Dragomir B. Krastev
, Andrew J. Wicks
, et al.
·
Cancer Research
·
45
Opinion: PARP inhibitors in cancer—what do we still need to know?
2022
·
Andrew J. Wicks
, Dragomir B. Krastev
, et al.
·
Open Biology
·
27
The transcriptomic architecture of common cancers reflects synthetic lethal interactions
2025
·
Syed Haider
, Rachel Brough
, et al.
·
Nature Genetics
·
21
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma
2025
·
James Stewart
, Dragomir B. Krastev
, et al.
·
Oncogene
·
19
PDF
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
2021
·
Ilirjana Bajrami
, Callum Walker
, et al.
·
Communications Biology
·
16
PDF
Pre-Treatment with BET Inhibitors Increases the Sensitivity of Cancer Cell Lines to Cisplatin and Oxaliplatin
2017
·
Andrew J. Wicks
·
Kent Academic Repository (University of Kent)
PDF
Show more works
View as search
Works count:
8
Citation count:
663
H-index:
7
I10-index:
7
Year
Topic
Type